A story in Xconomy reports that CMC ICOS has bounced back from the economic downturn. The company experienced 90% growth last year over prior year results and reached breakeven. Now it is running at 85% capacity and has begun hiring once more - up from 130 to 175 in past year.
CMC-ICOS says it has stable customer base of 8-10 clients currently. The CMO focuses on mid-size projects and clients not trying to compete head to head with the likes of Boehringer Ingelheim or Lonza.
Right now the company is making product for use in clinical trials exclusively and has no products that have reached commercial stages of approval. The goal is to make that transition in the next 12 months.
The company tries to compete by being nimble and responding very rapidly to customer needs.
"We're gaining market share, things are picking up," said President Gustavo Mahler.